Organon’s $954 Million Acquisition of Forendo Pharma

Krogerus and Wilmer Cutler Pickering Hale and Dorr advised Forendo Pharma on the deal. Organon, a global healthcare company formed through a spin-off from Merck, is…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here